Gainers
- Avenue Therapeutics (NASDAQ:ATXI) stock rose 77.1% to $0.41 during Wednesday's regular session. Avenue Therapeutics's stock is trading at a volume of 56.8 million shares as of 13:30 EST. This is 18245.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $9.0 million.
- bioAffinity Technologies (NASDAQ:BIAF) stock increased by 51.64% to $6.28. The current volume of 42.3 million shares is 800.8% of bioAffinity Technologies's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $17.1 million.
- NeuroOne Medical Tech (NASDAQ:NMTC) shares moved upwards by 24.3% to $2.25. As of 13:30 EST, this security is trading at a volume of 679.2K shares, making up 372.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $36.4 million.
- Tenax Therapeutics (NASDAQ:TENX) stock increased by 20.57% to $0.25. Tenax Therapeutics's stock is trading at a volume of 7.8 million shares as of 13:30 EST. This is 2911.4% of its average full-day volume over the last 100 days. The company's market cap stands at $6.3 million.
- Rhythm Pharmaceuticals (NASDAQ:RYTM) stock increased by 20.2% to $29.81. Trading volume for Rhythm Pharmaceuticals's stock is 1.2 million as of 13:30 EST. This is 49.9% of its average full-day volume over the last 100 days. The company's market cap stands at $1.5 billion.
- Fusion Pharmaceuticals (NASDAQ:FUSN) stock rose 19.89% to $3.52. Trading volume for Fusion Pharmaceuticals's stock is 125.8K as of 13:30 EST. This is 193.7% of its average full-day volume over the last 100 days. The company's market cap stands at $152.9 million.
Losers
- Comera Life Sciences (NASDAQ:CMRA) stock declined by 30.1% to $2.7 during Wednesday's regular session. As of 13:30 EST, Comera Life Sciences's stock is trading at a volume of 4.3 million, which is 89.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $51.5 million.
- Altimmune (NASDAQ:ALT) shares fell 25.72% to $15.14. Trading volume for this security as of 13:30 EST is 42.1 million, which is 2399.7% of its average full-day volume over the last 100 days. The company's market cap stands at $742.2 million.
- Caladrius Biosciences (NASDAQ:CLBS) shares decreased by 21.03% to $0.4. As of 13:30 EST, Caladrius Biosciences's stock is trading at a volume of 24.6 million, which is 17203.9% of its average full-day volume over the last 100 days. The company's market cap stands at $24.4 million.
- Rubius Therapeutics (NASDAQ:RUBY) shares fell 15.86% to $0.78. As of 13:30 EST, Rubius Therapeutics's stock is trading at a volume of 2.0 million, which is 72.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $70.4 million.
- BioLine Rx (NASDAQ:BLRX) shares declined by 14.89% to $1.43. As of 13:30 EST, this security is trading at a volume of 150.4K shares, making up 113.4% of its average full-day volume over the last 100 days. The company's market cap stands at $68.4 million.
- Aura Biosciences (NASDAQ:AURA) shares declined by 12.51% to $13.57. The market value of their outstanding shares is at $397.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
